Nurse Practitioner, Family · Irvine, CA
NPI
1205192713
Since 2012
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1000 Fivepoint
Irvine, CA, 92618
Phone (949) 671-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
536 services
Medicare patients, 2024
211
Average age 75
Drug cost, 2024
$4.5M
824 prescriptions
Company payments, 2025
$24.21
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly G Davey was code 99214 (office e&m - established), 304 times for 143 patients. In total Kelly G Davey billed 536 services in 11 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 304 | 143 | $68.11 | $21K |
| 99215 Office E&M - Established | Office | 125 | 53 | $105.58 | $13K |
| 99213 Office E&M - Established | Office | 40 | 37 | $47.69 | $1,908 |
| 38222 Other Organ Systems | Office | 38 | 38 | $54.39 | $2,067 |
By year: 2022 $3,793 for 68 services; 2023 $32K for 529 services; 2024 $40K for 536 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kelly G Davey prescribed most often to Medicare patients was Brukinsa (Zanubrutinib), with 77 prescriptions and refills. In total Kelly G Davey wrote 824 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Brukinsa Zanubrutinib | 77 | 77 | 14 | $884K |
| Prednisone Generic | 42 | 44 | 17 | $158 |
| Jaypirca Pirtobrutinib | 41 | 41 | Under 11 | $823K |
| Imbruvica Ibrutinib | 32 | 33 | Under 11 | $459K |
| Allopurinol Generic | 30 | 52 | 15 | $255 |
| Acyclovir Generic | 27 | 49 | 12 | $398 |
| Calquence Acalabrutinib Maleate | 25 | 25 | Under 11 | $248K |
| Erleada Apalutamide | 24 | 25 | Under 11 | $355K |
| Gabapentin Generic | 23 | 33 | Under 11 | $139 |
| Tagrisso Osimertinib Mesylate | 23 | 23 | Under 11 | $371K |
| Pantoprazole Sodium Generic | 23 | 49 | Under 11 | $273 |
| Ondansetron Hcl Generic | 19 | 19 | 11 | $132 |
| Prochlorperazine Maleate Generic | 19 | 19 | Under 11 | $397 |
| Venclexta Venetoclax | 19 | 19 | Under 11 | $242K |
| Letrozole Generic | 19 | 49 | Under 11 | $672 |
Brand drugs: 339 claims; generic drugs: 485 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly G Davey $24.21 ($24.21 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $24.21.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 1 | $24.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.